Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Gourley

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Hematology/Oncology Clinics of North America|November 5, 2018
Pathogenesis, Genetics, and Genomics of Non-High Grade Serous Ovarian CancersNarthana Ilenkovan, Charlie Gourley
Targeted Oncology|November 15, 2025
Targeting DNA Damage Repair Pathways Beyond PARP InhibitionEve Merry, Charlie Gourley
Expert Review of Anticancer Therapy|April 27, 2016
The safety and efficacy of olaparib therapy in patients with relapsed ovarian cancerRachel Nirsimloo, Charlie Gourley
Current Opinion in Oncology|August 5, 2015
Low-grade epithelial ovarian cancer: a number of distinct clinical entities?Ailsa J Oswald, Charlie Gourley
Critical Reviews in Oncology/Hematology|December 11, 2025
Cyclin E1 as a driver of oncogenesis; high grade serous ovarian cancer as an exemplarSarah J Taylor, Charlie Gourley
Cancer Treatment and Research|November 17, 2023
Development of Homologous Recombination Functional Assays for Targeting the DDRAilsa J Oswald, Charlie Gourley
Cancer Biology & Medicine|July 5, 2017
Erratum to Genetic and molecular changes in ovarian cancerRobert L Hollis, Charlie Gourley
Cancer Biology & Medicine|July 27, 2016
Genetic and molecular changes in ovarian cancerRobert L Hollis, Charlie Gourley
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2009
The use of cisplatin to treat advanced-stage cervical cancer during pregnancy allows fetal development and prevents cancer progression: report of a case and review of the literatureAngela Boyd, Valerie Cowie, Charlie Gourley
Gynecologic Oncology|January 10, 2016
Prediction of anti-angiogenesis escapeTakashi Mitamura, Charlie Gourley, Anil K Sood
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Hematology/Oncology Clinics of North America|November 5, 2018
Pathogenesis, Genetics, and Genomics of Non-High Grade Serous Ovarian CancersNarthana Ilenkovan, Charlie Gourley
Targeted Oncology|November 15, 2025
Targeting DNA Damage Repair Pathways Beyond PARP InhibitionEve Merry, Charlie Gourley
Expert Review of Anticancer Therapy|April 27, 2016
The safety and efficacy of olaparib therapy in patients with relapsed ovarian cancerRachel Nirsimloo, Charlie Gourley
Current Opinion in Oncology|August 5, 2015
Low-grade epithelial ovarian cancer: a number of distinct clinical entities?Ailsa J Oswald, Charlie Gourley
Critical Reviews in Oncology/Hematology|December 11, 2025
Cyclin E1 as a driver of oncogenesis; high grade serous ovarian cancer as an exemplarSarah J Taylor, Charlie Gourley
Cancer Treatment and Research|November 17, 2023
Development of Homologous Recombination Functional Assays for Targeting the DDRAilsa J Oswald, Charlie Gourley
Cancer Biology & Medicine|July 5, 2017
Erratum to Genetic and molecular changes in ovarian cancerRobert L Hollis, Charlie Gourley
Cancer Biology & Medicine|July 27, 2016
Genetic and molecular changes in ovarian cancerRobert L Hollis, Charlie Gourley
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2009
The use of cisplatin to treat advanced-stage cervical cancer during pregnancy allows fetal development and prevents cancer progression: report of a case and review of the literatureAngela Boyd, Valerie Cowie, Charlie Gourley
Gynecologic Oncology|January 10, 2016
Prediction of anti-angiogenesis escapeTakashi Mitamura, Charlie Gourley, Anil K Sood
Pageof 15